Zydus Wellness Limited — Q1FY27 earnings call summary

Filed 04 August 2026 · Company audio recording

Comfort Click business EPS accretive since Q4 FY26; margin and profit growth expected to continue despite seasonality.
International business grew 24.8% YoY; management expects sustained double-digit growth going forward.
Seasonal brands declined 12% due to unseasonal rains, but recovery expected in H2 FY27.
Innovation pipeline robust with new launches (Complan Powerplay RTD, Max Diabetes Care); focus on scaling recent launches.
Long-term launch pipeline strong with multiple product extensions across portfolios.
Seasonal portfolio impacted by unseasonal rains in North and East India causing softer demand and channel inventory buildup.
Pricing discipline maintained despite commodity and currency volatility.
Interest cost savings from GBP to Euro loan transition, but exposure to Euro benchmark rates remains.